Charlotte Maxeke Hospital continues cancer treatment amid licensing concerns Gauteng health authorities say four radiation machines remain operational, while two newly purchased machines await staffing and...
South Africans using weight-loss injections may need to reconsider how they access their treatment as authorities take action against the unauthorised compounding of certain medicines. The...
For thousands of South Africans trying to manage their weight, access to GLP-1 medication has become about more than simply getting a prescription. Recent regulatory and...
The Health Department says Enalapril 5mg supplied to public facilities is safe after SAHPRA ordered a recall of certain Enalapril 10mg Arya batches.
Health Department says the M72/ASO1E TB vaccine is in phase 3 trials in five countries and is preparing for expedited registration and roll-out once approved.
Alimatravir is an investigational once-a-month oral PrEP currently in Phase III trials. It is not yet available in South Africa and would need SAHPRA approval.
Generics, authorised low‑cost versions and regulatory action are reshaping South Africa’s GLP‑1 weight‑loss drug market as patients seek cheaper, safer access.
Police confiscate counterfeit goods worth nearly R78 million in major Limpopo operation More than 162,000 illicit items seized during coordinated law enforcement blitz A large-scale law...
Semaglutide and tirzepatide products are under scrutiny after South Africa’s health regulators warned against the use, prescription and dispensing of recalled iDEXIS medicines. The South African...
South Africa’s booming non-surgical aesthetics sector has created a rapidly expanding underground market where invasive cosmetic procedures are being offered outside regulated healthcare environments, industry sources...